The Anthrasil market is witnessing steady growth over the forecast period, supported by continued public health preparedness funding, expansion of biodefense stockpiles.
Read More
The Anthim market is witnessing steady growth over the forecast period, supported by continued biodefense investment, rising focus on pandemic and biosecurity readiness.
Read More
The Andexxa (Ondexxya) market is witnessing steady growth over the forecast period, supported by growth in cardiovascular disease prevalence, increased anticoagulant prescriptions.
Read More
The Anavip market is witnessing steady growth over the forecast period, supported by increasing awareness of effective snakebite treatment, expansion of emergency medical infrastructure.
Read More
The Anascorp market is witnessing steady growth over the forecast period, supported by climate driven venom spread, improved emergency access.
Read More
The Amvuttra market is witnessing steady growth over the forecast period, supported by expansion of rna based pipelines, rising diagnosis rates of amyloidosis.
Read More
The Amphadase market is witnessing steady growth over the forecast period, supported by rising outpatient procedures, expansion of aesthetic medicine.
Read More
The Amondys 45 market is witnessing steady growth over the forecast period, supported by advancements in gene-based therapies, broader newborn screening.
Read More
The Draximage MAA market is witnessing steady growth over the forecast period, supported by growth in respiratory disease burden, expansion of diagnostic imaging centers.
Read More
The Digifab market is witnessing steady growth over the forecast period, supported by aging population growth, rising cardiovascular disease prevalence.
Read More